Top Tweets for #her2negative
Breaking new ground at #ASCO25! Proud to share Dr. Erika Hamilton’s latest research on vepdegestrant in #ERpositive/#HER2negative metastatic #breastcancer, showing promising results for patients with ESR1 mutations. Learn more here: https://t.co/VeTH4sbGdp
Today at #ASCO25, I’ll be presenting findings from the VERITAC-2 study on vepdegestrant in ER+/HER2- metastatic #breastcancer, the most common subtype, demonstrating a 43% risk reduction in progression/death for ESR1-mutant patients. @NEJM https://t.co/GHvyyWVebZ
See a new #breastcancer activity via @PeerView @hoperugo @DrRFreedman #HER2negative #AgeFriendlyCare #MedEd https://t.co/nXjhPlzMk3
A 43-year-old premenopausal woman with HR+/HER2– early-stage #BreastCancer—what’s the best treatment approach? Ilana Schlam, MD, MPH (@DanaFarber) presents this clinical case challenge. Watch as she breaks it down: https://t.co/kUDv8kEyOn #DCIS #HER2Negative #BCSM @IlanaSchlam
INSEMA Trial: Can we safely omit sentinel #LymphNodeBiopsy in select #HR+/HER2- early-stage #BreastCancer patients? @DrSGraff, @ErinCobain & Manali Bhave, MD, discuss implications for #AdjuvantTherapy, CDK4/6 inhibitor eligibility. https://t.co/Khy8GCIqk4 #SABCS24 #HER2Negative
The MeCo Score tool may help to identify people with early HER2-negative breast cancer who are most likely to benefit from treatment that seems to reduce recurrence risk. https://t.co/NZRedaZGeR
#BreastCancer #BreastCancerResearch #BreastCancerAwareness #HER2negative
📹 The latest in CDK4/6 inhibitor therapy: With#Abemaciclib and ribociclib now options for HR+, #HER2Negative early #BreastCancer, experts discuss trial populations, schedules, and toxicity. https://t.co/3ApTzBOsP2 @DrSGraff @ErinCobain @WinshipAtEmory
The proportion of patients with an actionable alteration (AA) in serial cfDNA decreases with time - @ElisaAgostinett
@Nature_NPJ
https://t.co/rW7hvnVcaW
#oncodaily #oncology #cancer #npjJournalsBreast #cfDNA #metastaticbreastcancer #HRpositive #HER2negative #TNBC #HER2positive #precisionmedicine
Learn evidence-based strategies to guide clinical decision-making when treating #HRPositive, #HER2negative breast cancer from the experts in this new #MedEd activity: https://t.co/BcgtvXaEFE #OncTwitter @erikahamilton9 @jhaveri_komal
#JSMO2024 シンポジウム2
「HER2陰性乳癌の最適な周術期治療を考える」
分子生物学に基づいた薬剤開発と標準治療、今後の展望について意見交換をします！
2月22日（木） 13:40～15:10
Room 2（1号館4F「レセプションホール」）
by SNS-WG
#breastcancer #HER2negative #HER2low #immunotherapy #ADC
Transforming The Diagnosis And Treatment Of Breast Cancer - #AshleyGaines - Vice President, Head of Breast Cancer Franchise, US Oncology Business Unit, AstraZeneca #ProgressPotentialAndPossibilities #BreastCancer #Oncology #AstraZeneca #Truqap #Enhertu #HER2Negative #HER2Low #Tumors #Genomics #CompanionDiagnostics #DigitalHealth #Biomarkers #PI3K #AKT #PTEN #ProgressionFreeSurvival
Just published in #JCO: @ASCO rapid guideline update on testing for ESR1 mutations to guide therapy for #HRPositive, #HER2negative #metastaticbreastcancer 👉 https://t.co/EUuuhB8sMv #bcsm
We’ve issued a rapid guideline update for testing on ESR1 mutations to guide therapy for #HRPositive, #HER2negative #metastaticbreastcancer 👉 https://t.co/2iLbsI1AYx #bcsm
One year of adjuvant Olaparib was associated with significantly longer survival, free of invasive or distant disease, & significant overall survival benefit compared to placebo in #BRCA1/2 patients with #HER2negative #breastcancer
https://t.co/ABcfmElLdW
#TreadwellTherapeutics Announces #FastTrackDesignation Granted by the #FDA to #CFI402257 for the Treatment of #ERPositive/#HER2Negative #BreastCancer https://t.co/W6E6uS18Ys
For first time a #biomarker accurately predicts the efficacy of widely used #chemotherapy against #HER2negative #breastcancer. https://t.co/CjOrEfIlRk #oncology #breasttumors #biomarkers #cancer #CancerResearch #paclitaxel #proteomics #CDK4 #filamin #proteins #precisiononcology
Today at 12:30pm CST, Dr. Tara Sanft @tarasanftmd will present results from the neoadjuvant I-SPY 2 TRIAL in Hall 3 #SABCS22 #clinicaltrial #HER2negative #breastcancer #bcsm @SmilowCancer @YaleMed @YNHH @YaleBreast @SABCSSanAntonio
#Menarini Group Presents Updated Results from Pivotal Phase 3 #EMERALDTrial at the #SABCS22 that Demonstrate #Elacestrant's PFS Increases with Duration of Prior #CDK4i/#CDK46i in ER+, #HER2negative in Metastatic Setting https://t.co/GqGmvp7zrj
We are very proud of our teams contribution to today's @WeillCornell Research Retreat! @MarwaManai3 @ReduzziCarol @MCristofanill #HER2negative #metastaticbreastcancer #ctDNA #CTCs #MARCKS #InflammatoryBreastCancer
This past summer, @katiecouric was diagnosed with stage IA #HER2negative #breastcancer.
Her new mission is to raise awareness of the need for breast #cancerscreening & to educate women about #densebreasts.
Read more: https://t.co/Z27K5DbeaB #bcsm #OncTwitter @MedpageOnco
#becomevisible #dayeighteen #ERpositive #HER2negative #diep #bcam #bccww
"If we are to translate the silence surrounding breast cancer into LANGUAGE and ACTION against this scourge, then the first step is that women with mastectomies must become visible to each other" #audrelorde
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.1M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.6M followers
Taylor Swift
@taylorswift13
82.5M followers
Lady Gaga
@ladygaga
74M followers
Virat Kohli
@imvkohli
71.3M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.4M followers
Neymar Jr
@neymarjr
64.2M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.6M followers
X
@x
60.8M followers